Clinical Trials Logo

Clinical Trial Summary

The purpose of this randomized, double-blind, placebo-controlled, 5-period crossover study is to assess the effect of single oral doses of MK-1064 on latency to persistent sleep (LPS) as measured by polysomnography (PSG) in healthy young male participants, and to evaluate the safety and tolerability of single oral doses of MK-1064 and MK-6096 in healthy young male participants. The primary efficacy hypothesis is that at least one dose of MK-1064 is superior to placebo in decreasing LPS in healthy male participants as assessed by PSG.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02549027
Study type Interventional
Source Merck Sharp & Dohme Corp.
Contact
Status Completed
Phase Phase 1
Start date November 6, 2009
Completion date April 6, 2010

See also
  Status Clinical Trial Phase
Completed NCT03445962 - 19/5000 (SYNAPSOT21) Predictive Factors of Sleep Apnea Syndrome in Down Syndrome
Completed NCT06199596 - Alpha-s1 Casein Hydrolysate on Sleep N/A
Completed NCT02116686 - ECG Derived Respiration for Automated Screening of Sleep Disordered Breathing in Chronic Heart Failure Patients N/A
Completed NCT04417556 - Validation of Various Sleep Assessment Tools in SICU N/A
Recruiting NCT03477812 - Sleep and Nocturnal Enuresis: Ambulatory Polysomnographic Study
Completed NCT03782844 - Efficacy of Simple Continuous Positive Airway Pressure on Patients With Obstructive Sleep Apnea N/A
Recruiting NCT04340310 - Home Respiratory Polygraphy in Childhood Sleep Apnea-Hypopnea Syndrome (CHILDSLEEP).
Not yet recruiting NCT06260020 - Development and Validation of a Comprehensive Module for Management of Sleep Disorders in ASD Children N/A
Active, not recruiting NCT03834792 - Adverse Long-term Consequences of Sleep Disordered Breathing: The Ottawa Hospital (TOH) Sleep Database
Completed NCT02132273 - Use of an Educational Story to Prepare Children With Developmental Disabilities for Sleep Study N/A